HASTE Hypersonic Push Adds Defense Momentum but Doesn't Resolve Key Risks

What happened

Rocket Lab's HASTE suborbital launch vehicle is being positioned to capture growing hypersonic testing demand, as highlighted in a recent Zacks article, but this is a niche within the company's broader defense expansion. The latest 10-Q shows strong operational momentum with Q2 revenue up 62% to $234.1M and backlog at $2.36B, while HASTE missions contributed to launch services revenue recognition over time in Q2. However, the company's primary value drivers remain Neutron's medium-lift debut and the pending Iridium acquisition, both of which face significant execution and financing uncertainties. Neutron's first launch is still only 'targeted' for Q4 2026 with a narrowing window, and the Iridium deal requires multiple approvals and a $3.6B bridge that must be replaced with permanent financing. Thus, while HASTE underscores Rocket Lab's defense relevance, it does not alter the core investment thesis that the stock at $80 already prices in successful resolution of these binary events.

Implication

Investors should view the HASTE hypersonic opportunity as a positive but secondary element of Rocket Lab's defense portfolio, which already includes significant Space Force awards like the $266M suborbital launch agreement and $397M Flatellite deal. The core investment case still hinges on Neutron achieving first flight and Iridium closing with manageable dilution, both of which are unresolved and could swing the stock significantly. With a market cap near $46B and negative earnings, the valuation requires flawless execution on these binary catalysts; any slip could trigger multiple compression. The recent CEO insider selling of over 3M shares adds to caution, signaling potential lack of confidence near current levels. Given the master report's base case value of $82 and bear case of $64, current price offers poor risk-reward for new positions; waiting for clearer proof points or a pullback to the $65 entry level is prudent.

Thesis delta

The HASTE news reinforces Rocket Lab's positioning in the growing defense and hypersonic testing market, which is already a tailwind in the master report. However, it does not shift the thesis as the key uncertainties around Neutron timing and Iridium financing remain unchanged. The WAIT rating stands; confirmation of Neutron qualification or Iridium financing progress would be needed to upgrade the view.